The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease - Archive ouverte HAL Access content directly
Journal Articles Respiratory Research Year : 2021

The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease

, , (1, 2) , , , , , , (1, 2) ,
1
2
Flora Lemaire
  • Function : Author
Sandra Audonnet
Pierre Gaudry
  • Function : Author
Sandra Dury
  • Function : Author
  • PersonId : 933694
Julien Ancel
François Lebargy
  • Function : Author
  • PersonId : 933695
Franck Antonicelli
  • Function : Author
Richard Le Naour

Abstract

Background: In chronic obstructive pulmonary disease (COPD), lung-infiltrating inflammatory cells secrete proteases and participate in elastin breakdown and genesis of elastin-derived peptides (EP). In the present study, we hypothesized that the pattern of T lymphocytes cytokine expression may be modulated by EP in COPD patients. Methods: CD4 + and CD8 + T-cells, sorted from peripheral blood mononuclear cells (PBMC) collected from COPD patients (n = 29) and controls (n = 13) were cultured with or without EP. Cytokine expression in T-cell phenotypes was analyzed by multicolor flow cytometry, whereas desmosine concentration, a specific marker of elastin degradation, was measured in sera. Results: Compared with control, the percentage of IL-4 (Th2) producing CD4 + T-cells was decreased in COPD patients (35.3 ± 3.4% and 26.3 ± 2.4%, respectively, p < 0.05), whereas no significant differences were found with IFN-γ (Th1) and IL-17A (Th17). Among COPD patients, two subpopulations were observed based on the percentage of IL-4 (Th2) producing CD4 + T-cells, of which only one expressed high IL-4 levels in association with high levels of desmosine and strong smoking exposure (n = 7). Upon stimulation with VGVAPG, a bioactive EP motif, the percentage of CD4 + T cells expressing IL-4 significantly increased in COPD patients (p < 0.05), but not in controls. The VGVAPGinduced increase in IL-4 was inhibited in the presence of analogous peptide antagonizing VGVAPG/elastin receptor (S-gal) interactions. Conclusions: The present study demonstrates that the VGVAPG elastin peptide modulates CD4 + T-cells IL-4 production in COPD. Monitoring IL-4 in circulating CD4 + T-cells may help to better characterize COPD phenotypes and could open a new pharmacologic opportunity through CD4 + T-cells stimulation via the VGVAPG/S-gal receptor in order to favor an anti-inflammatory response in those COPD patients.
Fichier principal
Vignette du fichier
FloraLemaire_RespirRes_2021.pdf (1.25 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03170597 , version 1 (16-03-2021)

Identifiers

Cite

Flora Lemaire, Sandra Audonnet, Jeanne-Marie Perotin, Pierre Gaudry, Sandra Dury, et al.. The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease. Respiratory Research, 2021, 22 (1), ⟨10.1186/s12931-020-01609-4⟩. ⟨hal-03170597⟩

Collections

URCA P3CELL
49 View
46 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More